Benefits and Side-Effects of Electrochemotherapy in Veterinary Patients

Lowe, Ron

doi:10.1007/978-981-287-817-5_95

Cited by 1 publication

(2 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Cutaneous or subcutaneous tumors (primary or metastatic) of any histology, which cannot be satisfactorily treated with their respective first-line treatments ( 26 , 31 ).…”

Section: Materials Equipment and Patientsmentioning

confidence: 99%

See 1 more Smart Citation

Veterinary Guidelines for Electrochemotherapy of Superficial Tumors

Tellado¹,

Mir

Maglietti

2022

Front. Vet. Sci.

View full text Add to dashboard Cite

Electrochemotherapy (ECT) consists in the application of electric pulses to increase chemotherapeutic drug intake (bleomycin, cisplatin, or calcium) into the tumor cells. It has become a very valuable treatment option in veterinary oncology. It is an effective and safe treatment modality, which is not only beneficial as a palliative treatment, but also for a curative approach. Performing the treatment adequately will ensure the best results possible, in the minimum number of sessions, and reduce complications. Usually, only one session is enough to achieve excellent results, but the treatment can be repeated. Several sessions can be necessary in the case of incompletely treated or very extended lesions, as well as in the occurrence of new lesions. ECT is effective for superficial or oral tumors of any histology that are accessible to the electrodes. Intravenous bleomycin is the preferred drug and route of administration, leaving other ways of administration and drugs for selected cases. The guidelines presented here are destined to veterinarians who want to develop their understanding of the basis of ECT and wish to perform it adequately and effectively. In this paper, we also discuss common problems and how to solve them, and we include practical tips to improve the treatment results based on common questions and mistakes of beginner users.

show abstract

“…Cutaneous or subcutaneous tumors (primary or metastatic) of any histology, which cannot be satisfactorily treated with their respective first-line treatments ( 26 , 31 ).…”

Section: Materials Equipment and Patientsmentioning

confidence: 99%

“…Elective ECT treatment when other first-line therapies are possible. A thorough explanation of other treatment options had to be made, and they had to be rejected by the owner ( 31 , 34 ).…”

Section: Materials Equipment and Patientsmentioning

confidence: 99%